TickerTain — Make Analysis Fun Again

▶ 0:52 · $HIMS · Hims & Hers Stock Skyrockets 40%: What We Know Today | $HIMS

now playing · $HIMS

$HIMS···bullish· high· postravis hoium

Hims & Hers surges 40% on reported Novo Nordisk partnership for GLP-1 distribution

HIMS is positioned to become a major healthcare platform distributing branded GLP-1 drugs like Wegovy and Ozempic alongside compounded alternatives, leveraging its 2.5M user base…

$NVO···neutral· mediumtravis hoium

Novo Nordisk seeks new distribution channels as Ozempic/Wegovy revenue declines amid competition

NVO's GLP-1 revenue is flatlining and guided lower for 2026 due to Eli Lilly competition and price pressure, creating strong incentive to partner with telehealth platforms like HI…

←